Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO
NCT01913444
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Unable to enroll patients into study.
Conditions
Neonates on ECMO
Interventions
DRUG:
Recombinant Antithrombin
Sponsor
Children's Hospital Los Angeles